Ignite Creation Date:
2025-12-25 @ 3:54 AM
Ignite Modification Date:
2026-01-15 @ 9:05 PM
Study NCT ID:
NCT00771602
Status:
TERMINATED
Last Update Posted:
2015-06-23
First Post:
2008-10-10
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Alemtuzumab + Rituximab Consolidation in CLL
Sponsor:
Organization: